PEPGEN INC. Income Taxes Paid
PEPGEN INC. (PEPG) reported Income Taxes Paid of $49.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-06
- PEPGEN INC. income taxes paid, net for the quarter ending 2026-06-30 was $49.00K.
- PEPGEN INC. income taxes paid, net for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PEPGEN INC. income taxes paid, net for the quarter ending 2025-12-31 was -$4.00K.
- PEPGEN INC. income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- PEPGEN INC. income taxes paid, net for fiscal 2025 was $82.00K, a 15.49% increase from fiscal 2024.
- PEPGEN INC. income taxes paid, net for fiscal 2024 was $71.00K, a 97.37% decline from fiscal 2023.
- PEPGEN INC. income taxes paid, net for fiscal 2023 was $2.70M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $49.00K 10-Q · filed 2026-08-06 | $45.00K derived: sum of 3 quarters · filed 2026-08-06 | $45.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | -$4.00K derived: sum of 2 quarters · filed 2026-05-12 | -$4.00K derived: sum of 3 quarters · filed 2026-05-12 | -$4.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$4.00K derived: sum of 2 quarters · filed 2026-03-04 | -$4.00K derived: sum of 3 quarters · filed 2026-08-06 | $82.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $86.00K 10-Q · filed 2025-11-12 | $86.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $86.00K 10-Q · filed 2026-08-06 | $86.00K derived: sum of 3 quarters · filed 2026-08-06 | $86.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $86.00K 10-Q · filed 2026-05-12 | $86.00K derived: sum of 2 quarters · filed 2026-05-12 | $86.00K derived: sum of 3 quarters · filed 2026-05-12 | $157.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $71.00K derived: sum of 3 quarters · filed 2026-03-04 | $71.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $71.00K derived: sum of 2 quarters · filed 2025-11-12 | $71.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $71.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $2.70M 10-K · filed 2025-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |